FTY720 Inhibits Tumor Necrosis Factor-alpha-Induced Proliferation and Extracellular Signal-Regulated Kinase Phosphorylation of Human Smooth Muscle Cells.

Abstract : We investigated the effects of the sphingolipid FTY720 on tumor necrosis factor-alpha (TNF-alpha)-induced proliferation and signal transduction in human smooth muscle cells (SMC). We showed that clinically relevant concentrations of FTY720 inhibited TNF-alpha-induced SMC proliferation and extracellular signal-regulated kinase (ERK) phosphorylation. We concluded that FTY720 may be a useful drug to inhibit chronic vascular rejection.
Type de document :
Article dans une revue
Transplantation Proceedings, Elsevier, 2009, 41 (2), pp.705-6. 〈10.1016/j.transproceed.2008.12.017〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00410378
Contributeur : Marie Francoise Simon <>
Soumis le : jeudi 20 août 2009 - 11:11:17
Dernière modification le : vendredi 28 août 2009 - 15:43:37

Identifiants

Collections

Citation

Tomsen Böhler, Nassim Kamar, L. Etienne, Sylvain Galvani, Cindy Canivet, et al.. FTY720 Inhibits Tumor Necrosis Factor-alpha-Induced Proliferation and Extracellular Signal-Regulated Kinase Phosphorylation of Human Smooth Muscle Cells.. Transplantation Proceedings, Elsevier, 2009, 41 (2), pp.705-6. 〈10.1016/j.transproceed.2008.12.017〉. 〈inserm-00410378〉

Partager

Métriques

Consultations de la notice

166